# OnCo record ribociclib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ribociclib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ribociclib" ;
  schema:name "Ribociclib"@en ;
  schema:alternateName "Ribociclib Succinate and Letrozole"@en, "Kisqali Femara Co-Pack"@en, "Kisqali" ;
  schema:description "Ribociclib is the CDK4/6 inhibitor with the most consistent survival benefit, approved for a broad population of early breast cancer patients since 2024."@en ;
  schema:url <https://onco.cc/drugs/ribociclib/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Ribociclib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q27088552> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ribociclib> ;
  onco:status "approved" ;
  onco:modality "Small-molecule CDK4/6 inhibitor" ;
  onco:approval "US 2017: HR+/HER2- advanced breast cancer", "US 2024: Adjuvant stage II-III HR+/HER2- breast cancer at high risk of recurrence" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:targets <https://onco.cc/targets/cdk4-6/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:trials <https://onco.cc/trials/natalee/>, <https://onco.cc/trials/nct06726148/>, <https://onco.cc/trials/nct05867251/>, <https://onco.cc/trials/nct05358249/>, <https://onco.cc/trials/nct04417621/>, <https://onco.cc/trials/nct05768139/>, <https://onco.cc/trials/nct06065748/>, <https://onco.cc/trials/nct07002177/>, <https://onco.cc/trials/nct05563220/>, <https://onco.cc/trials/nct07085767/>, <https://onco.cc/trials/nct06757634/>, <https://onco.cc/trials/nct04862663/>, <https://onco.cc/trials/nct05573555/>, <https://onco.cc/trials/nct06380751/>, <https://onco.cc/trials/nct07647328/>, <https://onco.cc/trials/nct07405801/>, <https://onco.cc/trials/nct05827081/>, <https://onco.cc/trials/nct06760637/>, <https://onco.cc/trials/nct07054190/> .